IRIS
PASTINA, PIERPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.110
EU - Europa 2.494
AS - Asia 1.255
SA - Sud America 236
AF - Africa 83
OC - Oceania 6
Totale 7.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.052
GB - Regno Unito 668
RU - Federazione Russa 588
SG - Singapore 374
CN - Cina 367
IE - Irlanda 337
IT - Italia 245
BR - Brasile 203
VN - Vietnam 188
UA - Ucraina 131
SE - Svezia 120
DE - Germania 111
HK - Hong Kong 96
FR - Francia 91
FI - Finlandia 82
IN - India 52
BD - Bangladesh 51
ZA - Sudafrica 49
ES - Italia 38
TR - Turchia 34
CA - Canada 32
KR - Corea 21
BE - Belgio 19
PL - Polonia 16
MX - Messico 14
NL - Olanda 13
AR - Argentina 10
AT - Austria 10
IQ - Iraq 10
NG - Nigeria 10
IR - Iran 8
JP - Giappone 8
LT - Lituania 8
PK - Pakistan 8
ID - Indonesia 7
VE - Venezuela 7
AU - Australia 6
UZ - Uzbekistan 6
KE - Kenya 5
TN - Tunisia 5
CI - Costa d'Avorio 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
JO - Giordania 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 7.184
Salva come PNG Salva come JPEG
Città #
Southend 565
Dublin 326
Fairfield 288
Dallas 280
Ashburn 253
Singapore 244
Moscow 177
Chandler 169
San Jose 154
Santa Clara 139
Woodbridge 136
Ann Arbor 125
Wilmington 114
Houston 113
Seattle 111
Beijing 109
Jacksonville 104
Menlo Park 104
Hong Kong 91
Cambridge 86
New York 86
Siena 66
Ho Chi Minh City 60
Council Bluffs 54
Helsinki 47
Johannesburg 45
Princeton 43
Los Angeles 42
Munich 41
Fremont 40
Hefei 35
Hanoi 32
The Dalles 32
Dong Ket 30
Nanjing 28
Dearborn 27
Izmir 27
Buffalo 25
Shanghai 25
Lauterbourg 24
Florence 23
Málaga 23
Seoul 21
Brussels 19
Boardman 17
Rome 16
San Diego 16
San Mateo 14
London 13
Milan 13
Turku 13
Warsaw 13
Columbus 12
Falkenstein 12
Frankfurt am Main 12
Shenyang 12
Montreal 11
Toronto 11
Abuja 10
Atlanta 9
Da Nang 9
Denver 9
Hebei 9
Phoenix 9
Tianjin 9
Manchester 8
Nuremberg 8
Orem 8
Poplar 8
Redondo Beach 8
Stockholm 8
Tokyo 8
Vienna 8
Dhaka 7
Guangzhou 7
Haiphong 7
Jinan 7
Lancaster 7
Mumbai 7
Nanchang 7
Ningbo 7
São Paulo 7
Barnet 6
Belo Horizonte 6
Chennai 6
Fort Worth 6
Jiaxing 6
Lappeenranta 6
Rio de Janeiro 6
San Francisco 6
Zanjan 6
Brasília 5
Brooklyn 5
Changsha 5
Chicago 5
Espoo 5
Hangzhou 5
Mexico City 5
Miami 5
Ribeirão Preto 5
Totale 5.058
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 396
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 369
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 341
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 322
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 321
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 297
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 286
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 280
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 276
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 266
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 258
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 256
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 212
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 207
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 207
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 200
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide 187
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 166
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 165
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 159
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 153
null 139
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 138
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 136
In Regard to Kubicek et al. 133
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 131
null 130
null 126
Immunotherapy of colorectal cancer: new perspectives after a long path. 117
null 117
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 116
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 113
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 108
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 102
null 92
null 82
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review 81
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 64
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups 43
Totale 7.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/2022388 25 38 38 18 25 18 20 29 29 38 39 71
2022/2023533 26 60 77 80 50 86 11 40 51 31 9 12
2023/2024539 9 6 63 23 15 150 240 0 2 12 2 17
2024/2025867 27 36 110 52 109 58 17 65 41 31 114 207
2025/20262.630 182 272 250 345 682 121 294 72 77 173 90 72
Totale 7.292